COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013
Respiratory muscle function in type 2 diabetes mellitus Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008
The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004
Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009
A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
The association of pulmonary fibrosis with diabetes mellitus Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020 Year: 2020
Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020
Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007
Association between continuous positive airway pressure, weight change and glycaemic control in patients with type 2 diabetes Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020
Changes in lung function in a rodent model of diabetes mellitus Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018
Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003
Lung diffusion capacity variations in diabetes mellitus Source: Eur Respir J 2002; 20: Suppl. 38, 196s Year: 2002
Ventilatory response to hypercapnia in type 1 diabetes mellitus: role of autonomic neuropathy and metabolic control Source: Annual Congress 2009 - Lung function in adults and children Year: 2009
Impact of diabetes mellitus on MDR-TB outcome Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Cheyne-stokes-respiration is an independent modulator of systolic blood pressure in patients with diabetes mellitus type 2 Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017
Control of ventilation in patients with insulin-dependent diabetes mellitus complicated by autonomic neuropathy Source: Eur Respir J 2005; 26: Suppl. 49, 66s Year: 2005
Elevated breath glucose is related to respiratory symptoms and not to disease type, control, duration or complications in diabetes mellitus patients Source: Eur Respir J 2007; 30: Suppl. 51, 365s Year: 2007